GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Maxigen Biotech Inc (TPE:1783) » Definitions » Dividend Payout Ratio

Maxigen Biotech (TPE:1783) Dividend Payout Ratio : 0.00 (As of Jun. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Maxigen Biotech Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Maxigen Biotech's Dividend Payout Ratio for the months ended in Jun. 2024 was 0.00.

The historical rank and industry rank for Maxigen Biotech's Dividend Payout Ratio or its related term are showing as below:

TPE:1783' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.19   Med: 0.59   Max: 0.86
Current: 0.3


During the past 13 years, the highest Dividend Payout Ratio of Maxigen Biotech was 0.86. The lowest was 0.19. And the median was 0.59.

TPE:1783's Dividend Payout Ratio is ranked better than
69.45% of 275 companies
in the Medical Devices & Instruments industry
Industry Median: 0.44 vs TPE:1783: 0.30

As of today (2024-09-21), the Dividend Yield % of Maxigen Biotech is 2.28%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Maxigen Biotech was 5.13%. The lowest was 0.53%. And the median was 1.57%.

Maxigen Biotech's Dividends per Share for the months ended in Jun. 2024 was NT$0.00.

During the past 3 years, the average Dividends Per Share Growth Rate was -9.50% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Maxigen Biotech was 69.50% per year. The lowest was -9.50% per year. And the median was 30.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Maxigen Biotech Dividend Payout Ratio Historical Data

The historical data trend for Maxigen Biotech's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maxigen Biotech Dividend Payout Ratio Chart

Maxigen Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 0.86 0.59 - 0.27

Maxigen Biotech Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.09 - - -

Competitive Comparison of Maxigen Biotech's Dividend Payout Ratio

For the Medical Instruments & Supplies subindustry, Maxigen Biotech's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Maxigen Biotech's Dividend Payout Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Maxigen Biotech's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Maxigen Biotech's Dividend Payout Ratio falls into.



Maxigen Biotech Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Maxigen Biotech's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2023 )/ EPS without NRI (A: Dec. 2023 )
=0.5/ 1.852
=0.27

Maxigen Biotech's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2024 )/ EPS without NRI (Q: Jun. 2024 )
=0/ 0.687
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Maxigen Biotech (TPE:1783) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Maxigen Biotech Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Maxigen Biotech's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Maxigen Biotech Business Description

Traded in Other Exchanges
N/A
Address
No. 88, Keji 1st Rd, Guishan District, Taoyuan City, TWN, 333
Maxigen Biotech Inc specializes in the developing, manufacturing, and marketing of biomedical and cosmeceutical skincare products. It provides medical devices for orthopedic, ophthalmic, dental, and surgical applications. Skincare product categories include mask series, facial cleansing series, and body care series. The biomedical products segment is primarily engaged in the manufacturing and sales of collagen and bone materials, which forms the majority chunk of the revenue of the group. The consumer products segment is engaged in the manufacturing and sales of beauty care products.

Maxigen Biotech Headlines

No Headlines